These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome. Fonseca W; Lukacs NW; Ptaschinski C Front Immunol; 2018; 9():226. PubMed ID: 29515570 [TBL] [Abstract][Full Text] [Related]
67. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs. Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475 [TBL] [Abstract][Full Text] [Related]
71. Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants. Browne SK; Beeler JA; Roberts JN Vaccine; 2020 Jan; 38(2):101-106. PubMed ID: 31706809 [TBL] [Abstract][Full Text] [Related]
72. Respiratory syncytial virus suppression of the antiviral immune response: Implications for evaluation of candidate vaccines. Roberts NJ Vaccine; 2019 Dec; 37(51):7451-7454. PubMed ID: 31607601 [TBL] [Abstract][Full Text] [Related]
73. RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling. Brasier AR Viruses; 2020 Apr; 12(4):. PubMed ID: 32331282 [TBL] [Abstract][Full Text] [Related]
74. Respiratory syncytial virus reduces STAT3 phosphorylation in human memory CD8 T cells stimulated with IL-21. Antunes KH; Becker A; Franceschina C; de Freitas DDN; Lape I; da Cunha MD; Leitão L; Rigo MM; Pinto LA; Stein RT; de Souza APD Sci Rep; 2019 Nov; 9(1):17766. PubMed ID: 31780735 [TBL] [Abstract][Full Text] [Related]
75. The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B. Power UF; Plotnicky H; Blaecke A; Nguyen TN Vaccine; 2003 Dec; 22(2):168-76. PubMed ID: 14615143 [TBL] [Abstract][Full Text] [Related]
76. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Taleb SA; Al Thani AA; Al Ansari K; Yassine HM Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1817-1827. PubMed ID: 29876771 [TBL] [Abstract][Full Text] [Related]
77. Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections? Mahalingam S; Schwarze J; Zaid A; Nissen M; Sloots T; Tauro S; Storer J; Alvarez R; Tripp RA Microbes Infect; 2006 Jan; 8(1):285-93. PubMed ID: 16182587 [TBL] [Abstract][Full Text] [Related]
78. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection. Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Garofalo RP; Brasier AR J Virol; 2017 Mar; 91(6):. PubMed ID: 28077651 [TBL] [Abstract][Full Text] [Related]
79. Respiratory syncytial virus: prospects for new and emerging therapeutics. Jorquera PA; Tripp RA Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729 [TBL] [Abstract][Full Text] [Related]
80. Discovery of RSV-Induced BRD4 Protein Interactions Using Native Immunoprecipitation and Parallel Accumulation-Serial Fragmentation (PASEF) Mass Spectrometry. Mann M; Roberts DS; Zhu Y; Li Y; Zhou J; Ge Y; Brasier AR Viruses; 2021 Mar; 13(3):. PubMed ID: 33799525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]